Bank of New York Mellon’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.1M | Buy |
553,462
+30,699
| +6% | +$2.22M | 0.01% | 1127 |
|
|
2026
Q1 | $35.6M | Buy |
522,763
+8,083
| +2% | +$572K | 0.01% | 1208 |
|
|
2025
Q4 | $39.1M | Buy |
514,680
+241,604
| +88% | +$17.6M | 0.01% | 1159 |
|
|
2025
Q3 | $16.8M | Buy |
273,076
+6,905
| +3% | +$360K | ﹤0.01% | 1637 |
|
|
2025
Q2 | $13M | Buy |
266,171
+49,728
| +23% | +$2.36M | ﹤0.01% | 1748 |
|
|
2025
Q1 | $11M | Sell |
216,443
-439
| -0.2% | -$21.9K | ﹤0.01% | 1807 |
|
|
2024
Q4 | $9.79M | Sell |
216,882
-1,315
| -0.6% | -$56.3K | ﹤0.01% | 1934 |
|
|
2024
Q3 | $8.1M | Sell |
218,197
-60,852
| -22% | -$2.04M | ﹤0.01% | 2045 |
|
|
2024
Q2 | $8.53M | Buy |
279,049
+40,840
| +17% | +$1.32M | ﹤0.01% | 2044 |
|
|
2024
Q1 | $6.93M | Sell |
238,209
-20,332
| -8% | -$570K | ﹤0.01% | 2157 |
|
|
2023
Q4 | $7.13M | Sell |
258,541
-49,069
| -16% | -$1.12M | ﹤0.01% | 2191 |
|
|
2023
Q3 | $6.89M | Sell |
307,610
-642,806
| -68% | -$23.9M | ﹤0.01% | 2156 |
|
|
2023
Q2 | $38.7M | Sell |
950,416
-14,890
| -2% | -$729K | 0.01% | 1174 |
|
|
2023
Q1 | $46.8M | Sell |
965,306
-14,210
| -1% | -$650K | 0.01% | 1047 |
|
|
2022
Q4 | $37.4M | Sell |
979,516
-35,778
| -4% | -$1.49M | 0.01% | 1168 |
|
|
2022
Q3 | $51M | Sell |
1,015,294
-2,576
| -0.3% | -$126K | 0.01% | 946 |
|
|
2022
Q2 | $40.8M | Sell |
1,017,870
-48,525
| -5% | -$1.7M | 0.01% | 1114 |
|
|
2022
Q1 | $39.8M | Sell |
1,066,395
-50,081
| -4% | -$1.93M | 0.01% | 1249 |
|
|
2021
Q4 | $44.5M | Sell |
1,116,476
-107,751
| -9% | -$4.12M | 0.01% | 1246 |
|
|
2021
Q3 | $45.6M | Buy |
1,224,227
+9,630
| +0.8% | +$396K | 0.01% | 1193 |
|
|
2021
Q2 | $51.3M | Buy |
1,214,597
+409,436
| +51% | +$17.5M | 0.01% | 1120 |
|
|
2021
Q1 | $38.1M | Buy |
805,161
+29,689
| +4% | +$1.76M | 0.01% | 1294 |
|
|
2020
Q4 | $47.3M | Buy |
775,472
+31,385
| +4% | +$1.85M | 0.01% | 1076 |
|
|
2020
Q3 | $34.8M | Sell |
744,087
-291
| -0% | -$14.3K | 0.01% | 1117 |
|
|
2020
Q2 | $37.8M | Buy |
744,378
+397,731
| +115% | +$19.5M | 0.01% | 1053 |
|
|
2020
Q1 | $15.5M | Buy |
346,647
+27,527
| +9% | +$1.39M | 0.01% | 1442 |
|
|
2019
Q4 | $15.3M | Buy |
319,120
+12,363
| +4% | +$525K | ﹤0.01% | 1725 |
|
|
2019
Q3 | $10.4M | Sell |
306,757
-2,539
| -0.8% | -$111K | ﹤0.01% | 1908 |
|
|
2019
Q2 | $13.9M | Buy |
309,296
+7,592
| +3% | +$300K | ﹤0.01% | 1777 |
|
|
2019
Q1 | $11.4M | Buy |
301,704
+43,700
| +17% | +$1.47M | ﹤0.01% | 1901 |
|
|
2018
Q4 | $8.85M | Buy |
258,004
+65,061
| +34% | +$2.34M | ﹤0.01% | 1979 |
|
|
2018
Q3 | $9.07M | Buy |
192,943
+7,113
| +4% | +$294K | ﹤0.01% | 2074 |
|
|
2018
Q2 | $6.27M | Buy |
185,830
+6,600
| +4% | +$206K | ﹤0.01% | 2271 |
|
|
2018
Q1 | $4.85M | Buy |
179,230
+60
| +0% | +$1.52K | ﹤0.01% | 2373 |
|
|
2017
Q4 | $2.99M | Buy |
179,170
+7,693
| +4% | +$130K | ﹤0.01% | 2612 |
|
|
2017
Q3 | $3.43M | Buy |
171,477
+9,469
| +6% | +$185K | ﹤0.01% | 2523 |
|
|
2017
Q2 | $2.97M | Sell |
162,008
-20,040
| -11% | -$270K | ﹤0.01% | 2606 |
|
|
2017
Q1 | $1.79M | Buy |
182,048
+20,123
| +12% | +$244K | ﹤0.01% | 2913 |
|
|
2016
Q4 | $1.77M | Sell |
161,925
-5,219
| -3% | -$54.8K | ﹤0.01% | 2932 |
|
|
2016
Q3 | $2.34M | Buy |
167,144
+17,076
| +11% | +$139K | ﹤0.01% | 2658 |
|
|
2016
Q2 | $1.05M | Buy |
150,068
+5,044
| +3% | +$37K | ﹤0.01% | 3102 |
|
|
2016
Q1 | $934K | Sell |
145,024
-5,497
| -4% | -$95.4K | ﹤0.01% | 3105 |
|
|
2015
Q4 | $4.88M | Buy |
150,521
+6,055
| +4% | +$178K | ﹤0.01% | 2225 |
|
|
2015
Q3 | $3.86M | Sell |
144,466
-17,409
| -11% | -$745K | ﹤0.01% | 2375 |
|
|
2015
Q2 | $7.79M | Buy |
161,875
+23,009
| +17% | +$1.34M | ﹤0.01% | 2091 |
|
|
2015
Q1 | $8.45M | Sell |
138,866
-9,349
| -6% | -$570K | ﹤0.01% | 2028 |
|
|
2014
Q4 | $7.67M | Buy |
148,215
+6,038
| +4% | +$266K | ﹤0.01% | 2074 |
|
|
2014
Q3 | $6.26M | Buy |
142,177
+1,796
| +1% | +$56.2K | ﹤0.01% | 2171 |
|
|
2014
Q2 | $3.67M | Buy |
140,381
+87,261
| +164% | +$1.87M | ﹤0.01% | 2508 |
|
|
2014
Q1 | $1.39M | Buy |
53,120
+12,240
| +30% | +$329K | ﹤0.01% | 3113 |
|
|
2013
Q4 | $693K | Buy |
40,880
+15,323
| +60% | +$269K | ﹤0.01% | 3463 |
|
|
2013
Q3 | $548K | Buy |
+25,557
| New | +$444K | ﹤0.01% | 3483 |
|
Other funds holding PTCT
RI
JT
Bank of New York Mellon's PTCT Position: Q2 2026 in Review
Bank of New York Mellon increased its PTC Therapeutics (PTCT) stake by 5.9% in Q2 2026, buying an estimated $2.22M and bringing the position to 553,462 shares worth $45.1M. The position accounts for 0.01% of the portfolio, ranked #1127.
Bank of New York Mellon first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. The position peaked at $51.3M in Q2 2021. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Bank of New York Mellon held 553,462 shares of PTC Therapeutics worth $45.1M as of Q2 2026.
- Bank of New York Mellon bought 30,699 PTC Therapeutics shares in Q2 2026, an estimated $2.22M.
- PTC Therapeutics made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1127 holding.
- Bank of New York Mellon first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- Bank of New York Mellon's PTC Therapeutics position peaked at $51.3M in Q2 2021.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.